logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mingzhao Xing

Southern University of Science and Technology

70H指数
195论文数
2.2W被引数
收录论文 103
发表时间
logo
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study乳头状甲状腺癌AJCC分类的基因修饰：一项国际、多中心、回顾性队列研究
errThe Lancet Oncology
IF0
err2025-09-29
err0
PREAI
errMingzhao Xing; Shuhuang Lin; Aarti Mathur; Ying Li; Bela Bendlova; Vlasta Kuklikova; Miguel Melo; Tito Teles Jesus; Paula Soares; Carla Colombo; Laura Fugazzola; Norisato Mitsutake; Michiko Matsuse; Ayaka Sako; Ana Patricia Estrada-Florez; Luis G Carvajal-Carmona; Mabel E Bohórquez; Caterina Mian; Federica Vianello; Christine J O'Neill; Roderick Clifton-Bligh; Agnieszka Czarniecka; Barbara Jarzab; Chan Kwon Jung; Bayu Brahma; Paul W Ladenson; Young Joo Park
err分享
err收藏
Efficacy and Safety of Targeted Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer碘难治性分化型甲状腺癌靶向治疗的疗效和安全性
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-09-18
err1
errOAAI
errZhang, Yuqing; Zhang, Xiaoxin; Lin, Lifan; Xing, Mingzhao
err分享
err收藏
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathway
errMOLECULAR ONCOLOGY
IF4.5
err2024-07-20
err0
errOAAI
errShen, Xiaopei; Tan, Jie; Liu, Rengyun; Zhu, Guangwu; Rooper, Lisa; Xing, Mingzhao
err分享
err收藏
Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-05-13
err2
errOAAI
errZhang, Wei; Lin, Shuhuang; Wang, Zhuo; Zhang, Wenyong; Xing, Mingzhao
err分享
err收藏
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2023-12-19
err3
PREAI
errLiu, Rengyun; Zhu, Guangwu; Tan, Jie; Shen, Xiaopei; Xing, Mingzhao
err分享
err收藏
Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2023-12-08
err1
errOAAI
errLin, Shuhuang; Wang, Zhuo; Xing, Mingzhao
err分享
err收藏
A Feedback Loop Involving Exosomal miR-146a and NG2 to Propel the Development and Progression of Hypothyroidism
errTHYROID
IF6.7
err2023-08-16
err2
PREAI
errSui, Fang; Chen, Pu; Feng, Chao; Yang, Qi; Zhang, Shaoqiang; Ji, Meiju; Wang, Yinan; Guan, Haixia; Xing, Mingzhao; Hou, Peng
err分享
err收藏
Hypoxia switches TET1 from being tumor-suppressive to oncogenic
errONCOGENE
IF7.3
err2023-04-05
err3
errOAAI
errYang, Qi; Dang, Hui; Liu, Jiaxin; Wang, Xingye; Wang, Jingyuan; Lan, Xinhui; Ji, Meiju; Xing, Mingzhao; Hou, Peng
err分享
err收藏
Response to Letter to the Editor from Boucai and Tuttle: BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2022-03-09
err0
errOAAI
errXing, Mingzhao
err分享
err收藏
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerBRAF V600E状态可显著区分乳头状甲状腺癌的淋巴结转移相关死亡风险
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2021-07-17
err40
errOAAI
errTao, Yubing; Wang, Fei; Shen, Xiaopei; Zhu, Guangwu; Liu, Rengyun; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Neill, Christine J.; Sywak, Mark S.; Clifton-Bligh, Roderick; Bendlova, Bela; Sykorova, Vlasta; Zhao, Shihua; Wang, Yangang; Xing, Mingzhao
err分享
err收藏
Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2
errPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
err2021-03-08
err20
errOAAI
errLiu, Rengyun; Tan, Jie; Shen, Xiaopei; Jiang, Ke; Wang, Chaoqun; Zhu, Guangwu; Xing, Mingzhao
err分享
err收藏
ABO Blood Group Correlations with Covid-19: Cohort Choice Makes A Difference Reply
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2020-09-28
err0
PREAI
errZhao, Jiao; Xing, Mingzhao; Wang, Peng George
err分享
err收藏
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2020-08-04
err294
errOAAI
errZhao, Jiao; Yang, Yan; Huang, Hanping; Li, Dong; Gu, Dongfeng; Lu, Xiangfeng; Zhang, Zheng; Liu, Lei; Liu, Ting; Liu, Yukun; He, Yunjiao; Sun, Bin; Wei, Meilan; Yang, Guangyu; Wang, Xinghuan; Zhang, Li; Zhou, Xiaoyang; Xing, Mingzhao; Wang, Peng George
err分享
err收藏
TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel
errPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
err2020-06-19
err37
errOAAI
errTan, Jie; Liu, Rengyun; Zhu, Guangwu; Umbricht, Christopher B.; Xing, Mingzhao
err分享
err收藏
Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2020-04-09
err152
errOAAI
errZhao, Juanjuan; Liao, Xuejiao; Wang, Haiyan; Wei, Lanlan; Xing, Mingzhao; Liu, Lei; Zhang, Zheng
err分享
err收藏
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaBRAF V600E状态可能有助于对低危甲状腺乳头状微小癌进行主动监测的决策
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2020-01-01
err39
errOAAI
errKim, Kyeong J.; Kim, Sin G.; Tan, Jie; Shen, Xiaopei; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Neill, Christine J.; Sywak, Mark S.; Clifton-Bligh, Roderick; Bendlova, Bela; Sykorova, Vlasta; Xing, Mingzhao
err分享
err收藏
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2019-08-02
err98
errOAAI
errLiu, Jiajun; Liu, Rengyun; Shen, Xiaopei; Zhu, Guangwu; Li, Biao; Xing, Mingzhao
err分享
err收藏
Stage II Differentiated Thyroid Cancer Is a High-Risk Disease in Patients <45/55 Years Old
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2019-05-22
err6
errOAAI
errLiu, Zeming; Shen, Xiaopei; Liu, Rengyun; Zhu, Guangwu; Huang, Tao; Xing, Mingzhao
err分享
err收藏
Identification and characterization of two novel oncogenic mTOR mutations
errONCOGENE
IF7.3
err2019-03-27
err31
errOAAI
errMurugan, Avaniyapuram Kannan; Liu, Rengyun; Xing, Mingzhao
err分享
err收藏
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
errNATURE COMMUNICATIONS
IF15.7
err2018-02-08
err152
errOAAI
errLiu, Rengyun; Zhang, Tao; Zhu, Guangwu; Xing, Mingzhao
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
A
Andreas von Deimling
H 指数: 175 · 论文数: 1.8K
D
David Sidransky
H 指数: 144 · 论文数: 1.7K
A
Adel K. El‐Naggar
H 指数: 132 · 论文数: 1.3K
L
L. Sylvia
H 指数: 132 · 论文数: 928
E
Electron Kebebew
H 指数: 114 · 论文数: 688
查看更多